Share of the population living with HIV receiving antiretroviral therapy in Cape Verde

Cape Verde: Share of the population living with HIV receiving antiretroviral therapy was 80.3% in 2024. ◆ Volatile

Latest (2024)
80.3%
Change on year
up 4.7%
World rank
51st
of 149 countries
All-time high
81.4%
in 2021
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Cape Verde, 1990–2024

0204060801990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 0 %1996: 0 %1997: 0 %1998: 0 %1999: 0 %2000: 0.067 %2001: 0.129 %2002: 0.188 %2003: 0.245 %2004: 0.692 %2005: 9 %2006: 14.1 %2007: 20.5 %2008: 25.8 %2009: 25.6 %2010: 31.6 %2011: 35.1 %2012: 41.7 %2013: 48.5 %2014: 52.6 %2015: 52.5 %2016: 52.6 %2017: 59.5 %2018: 68.2 %2019: 71.4 %2020: 75.6 %2021: 81.4 %2022: 78.9 %2023: 76.7 %2024: 80.3 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

Cape Verde recorded 80.3% for share of the population living with hiv receiving antiretroviral therapy in 2024.

Compared with earlier readings it is up 4.7% on the previous year and up 52.6% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Cape Verde peaked at 81.4% in 2021 and was at its lowest, 0.0%, in 1990.

That places Cape Verde 51st out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Cape Verde, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Cape Verde, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 0.0% —
1996 0.0% —
1997 0.0% —
1998 0.0% —
1999 0.0% —
2000 0.1% —
2001 0.1% +91.8%
2002 0.2% +45.5%
2003 0.2% +30.2%
2004 0.7% +182.2%
2005 9.0% +1195.2%
2006 14.1% +57.8%
2007 20.5% +45.2%
2008 25.8% +25.6%
2009 25.6% -0.6%
2010 31.6% +23.2%
2011 35.1% +11.1%
2012 41.7% +18.9%
2013 48.5% +16.4%
2014 52.6% +8.4%
2015 52.5% -0.3%
2016 52.6% +0.2%
2017 59.5% +13.2%
2018 68.2% +14.5%
2019 71.4% +4.7%
2020 75.6% +5.9%
2021 81.4% +7.7%
2022 78.9% -3.1%
2023 76.7% -2.8%
2024 80.3% +4.7%

Cape Verde compared with similar countries

  • Cape Verde's 80.3% is above the median for upper middle income countries, which is 65.5%, 1.2× the median. (43 countries reporting)
  • Cape Verde's 80.3% is below the median for Sub-Saharan Africa, which is 81.2%, 99% of the median. (44 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Cape Verde changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2005 +1195.2% 0.7% 9.0%
2004 +182.2% 0.2% 0.7%

Averages by decade

DecadeAverage LowestHighest Years
1990s 0.0% 0.0% 0.0% 10
2000s 9.6% 0.1% 25.8% 10
2010s 51.4% 31.6% 71.4% 10
2020s 78.6% 75.6% 81.4% 5

Countries ranked near Cape Verde

  1. 48 Mozambique 81.9% compare
  2. 49 Tajikistan 81.2% compare
  3. 50 South Africa 80.6% compare
  4. 52 Peru 80.1% compare
  5. 53 Argentina 79.3% compare
  6. 54 Guinea-Bissau 79.2% compare

See the full ranking of 149 places →

More reference data data for Cape Verde

All data for Cape Verde →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Cape Verde?
Share of the population living with hiv receiving antiretroviral therapy in Cape Verde was 80.3% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Cape Verde?
The highest recorded value was 81.4% in 2021.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Cape Verde?
The lowest recorded value was 0.0% in 1990.
How does Cape Verde rank for share of the population living with hiv receiving antiretroviral therapy?
Cape Verde ranks 51st out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Cape Verde?
Over the last ten years it is up 52.6%. The long-run trend across the full record is volatile.
Where does this Cape Verde data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Cape Verde. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/cabo-verde/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/cabo-verde/">Share of the population living with HIV receiving antiretroviral therapy in Cape Verde</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.